Haemonetics Corp (HAE)

EBITDA Margin

22.01%

Quarterly · Period ending:

HAE logo

HAE EBITDA Margin

Latest reported22.01%
HAE Quarterly EBITDA Margin (100.00% → 22.01%)
High-resolution chart · PNG

HAE ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Haemonetics Corp EBITDA Margin — Quarterly
Period endingEBITDA Margin
43.0179%
45.5263%
22.3995%
20.1672%
20.5401%
17.6716%
20.1977%
23.607%
23.0101%
16.8011%
21.1765%
25.3687%
17.2222%
51.272%
19.2612%
19.7128%
18.1045%
15.4862%
18.9295%
22.3118%
23.0464%
19.4602%
25.8941%
25.9045%
25.7267%
23.3138%
25.4573%
26.6462%
25.7504%
25.273%
25.9494%
25.7188%
23.5897%
23.3043%
23.8179%
23.5405%
22.6337%
21.875%
21.3333%
20.6019%
19.4514%
100%
100%
100%
100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.